agilon health inc expected to post a loss of 12 cents a share - Earnings Preview

agilon health

03/08/2026 22:44

agilon health inc AGL.N, AGL is expected to  show a rise in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The Westerville Ohio-based  company is expected to report a 3.9% increase in revenue to $1.45 billion from $1.39 billion a year ago, according to the mean estimate from 15 analysts, based on LSEG data.The company's guidance on May 6 2026, for the period ended June 30, was for revenue between $1.44 billion and $1.48 billion.
​LSEG's mean analyst estimate for agilon health inc is for a loss of 12 cents per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 9 "hold" and 4 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for agilon health inc is $81.00, about 13.9% below its last closing price of $94.11
The company's guidance on May 6 2026 for the period ended June 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between USD1.435 billion and USD25 million.
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
0.83
0.94
1.80
Beat
91.8
Dec. 31 2026
-6.72
-6.72
-11.50
Missed
-71.2
Sep. 30 2025
-4.09
-3.96
-6.75
Missed
-70.6​
Jun. 30 2025
-3.07
-2.88
-6.25
Missed
-116.8
​​Mar. 31 2025
-0.37
-0.23
0.75
Beat
425.7
Dec. 31 2024
-5.69
-5.71
-6.50
Missed
-13.8​
Sep. 30 2024
-2.66
-2.65
-7.25
Missed
-173.8
Jun. 30 2024
-2.14
-2.02
-1.75
Beat
13.3
This summary was machine generated August 3 at 21:44 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)